Marina V. Karg

842 total citations
17 papers, 422 citations indexed

About

Marina V. Karg is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marina V. Karg has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marina V. Karg's work include Diabetes Treatment and Management (6 papers), Blood Pressure and Hypertension Studies (5 papers) and Sodium Intake and Health (3 papers). Marina V. Karg is often cited by papers focused on Diabetes Treatment and Management (6 papers), Blood Pressure and Hypertension Studies (5 papers) and Sodium Intake and Health (3 papers). Marina V. Karg collaborates with scholars based in Germany, Belarus and Poland. Marina V. Karg's co-authors include Roland E. Schmieder, Kristina Striepe, Christian Ott, Dennis Kannenkeril, Agnes Bosch, Peter Bramlage, Agnes Jumar, Stefanie Friedrich, Susanne Jung and Peter Linz and has published in prestigious journals such as Journal of Vascular Surgery, Journal of Hypertension and European Journal of Heart Failure.

In The Last Decade

Marina V. Karg

13 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina V. Karg Germany 7 309 145 129 111 68 17 422
Kristina Striepe Germany 10 362 1.2× 195 1.3× 154 1.2× 129 1.2× 81 1.2× 33 539
Agnes Bosch Germany 13 295 1.0× 218 1.5× 150 1.2× 124 1.1× 106 1.6× 45 568
Susanne Jung Germany 11 183 0.6× 175 1.2× 82 0.6× 68 0.6× 59 0.9× 30 364
Eita Kumagai Japan 12 124 0.4× 133 0.9× 64 0.5× 70 0.6× 37 0.5× 28 393
Yshai Yavin United States 10 262 0.8× 69 0.5× 98 0.8× 98 0.9× 69 1.0× 20 351
Darryl Meeking United Kingdom 10 124 0.4× 156 1.1× 65 0.5× 62 0.6× 28 0.4× 32 453
Lasse Bent-Hansen Denmark 10 150 0.5× 112 0.8× 60 0.5× 62 0.6× 57 0.8× 15 381
Jimmy Ren United States 4 374 1.2× 116 0.8× 173 1.3× 143 1.3× 44 0.6× 8 439
Donna Shu‐Han Lin Taiwan 9 200 0.6× 83 0.6× 83 0.6× 57 0.5× 55 0.8× 26 302
Maria G. Dekker Canada 9 201 0.7× 134 0.9× 65 0.5× 70 0.6× 28 0.4× 9 474

Countries citing papers authored by Marina V. Karg

Since Specialization
Citations

This map shows the geographic impact of Marina V. Karg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina V. Karg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina V. Karg more than expected).

Fields of papers citing papers by Marina V. Karg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina V. Karg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina V. Karg. The network helps show where Marina V. Karg may publish in the future.

Co-authorship network of co-authors of Marina V. Karg

This figure shows the co-authorship network connecting the top 25 collaborators of Marina V. Karg. A scholar is included among the top collaborators of Marina V. Karg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina V. Karg. Marina V. Karg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Bosch, Agnes, Joanna Haraźny, Axel Schmid, et al.. (2025). Renal denervation increases capillary density in hypertensive patients. European Journal of Preventive Cardiology. 1 indexed citations
3.
Kannenkeril, Dennis, Julie Kolwelter, Peter Linz, et al.. (2025). Short- and Mid-Term Effects of Empagliflozin on Sodium Balance and Fluid Regulation in Chronic Heart Failure. European Journal of Heart Failure. 27(12). 3134–3141.
4.
Kannenkeril, Dennis, Axel Schmid, Kristina Striepe, et al.. (2025). Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease. Clinical Kidney Journal. 18(7). sfaf184–sfaf184.
5.
Karg, Marina V., et al.. (2024). OPTINOFA – Intelligenter Assistenzdienst zur strukturierten Ersteinschätzung in der Notaufnahme. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 120(3). 208–221. 1 indexed citations
6.
Kannenkeril, Dennis, Kristina Striepe, Agnes Bosch, et al.. (2024). Predicting blood pressure response to renal denervation based on a new approach. Journal of Hypertension. 43(3). 413–419.
7.
Bosch, Agnes, Dennis Kannenkeril, Susanne Jung, et al.. (2020). The influence of aircraft noise exposure on the systemic and renal haemodynamics. European Journal of Preventive Cardiology. 29(1). 116–124. 6 indexed citations
8.
Kannenkeril, Dennis, Marina V. Karg, Agnes Bosch, et al.. (2019). Tissue sodium content in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 33(7). 485–489. 24 indexed citations
9.
Bosch, Agnes, Christian Ott, Susanne Jung, et al.. (2019). How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial. Cardiovascular Diabetology. 18(1). 44–44. 85 indexed citations
10.
Jung, Susanne, Agnes Bosch, Dennis Kannenkeril, et al.. (2019). Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes. European Heart Journal - Cardiovascular Pharmacotherapy. 6(6). 364–371. 12 indexed citations
11.
Bosch, Agnes, Axel Schmid, Christian Ott, et al.. (2019). Copeptin Levels in Patients With Treatment-Resistant Hypertension Before and 6 Months After Renal Denervation. American Journal of Hypertension. 33(2). 182–189. 1 indexed citations
12.
Bosch, Annemien E. van den, Dennis Kannenkeril, Claus‐Eric Ott, et al.. (2019). THE INFLUENCE OF ANNOYANCE DUE TO AIRCRAFT NOISE ON RENAL HEMODYNAMIC. Journal of Hypertension. 37. e200–e200. 1 indexed citations
13.
Karg, Marina V., Agnes Bosch, Dennis Kannenkeril, et al.. (2018). SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovascular Diabetology. 17(1). 5–5. 146 indexed citations
14.
Kannenkeril, Dennis, Agnes Bosch, Joanna Haraźny, et al.. (2018). Early vascular parameters in the micro- and macrocirculation in type 2 diabetes. Cardiovascular Diabetology. 17(1). 128–128. 16 indexed citations
15.
Ott, Christian, Agnes Jumar, Kristina Striepe, et al.. (2017). A Randomized Study of the Impact of the SGLT2 Inhibitor Dapagliflozin on Microvascular and Macrovascular Circulation. Journal of Vascular Surgery. 65(6). 1863–1863. 1 indexed citations
16.
Schneider, Andreas, Johannes Schwab, Marina V. Karg, et al.. (2017). Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension. Journal of Hypertension. 35(5). 1086–1092. 15 indexed citations
17.
Ott, Christian, Agnes Jumar, Kristina Striepe, et al.. (2017). A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation. Cardiovascular Diabetology. 16(1). 26–26. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina Striepe Breakdown of academic impact, for papers by Agnes Bosch Breakdown of academic impact, for papers by Susanne Jung Breakdown of academic impact, for papers by Eita Kumagai Breakdown of academic impact, for papers by Yshai Yavin Breakdown of academic impact, for papers by Darryl Meeking Breakdown of academic impact, for papers by Lasse Bent-Hansen Breakdown of academic impact, for papers by Jimmy Ren Breakdown of academic impact, for papers by Donna Shu‐Han Lin Breakdown of academic impact, for papers by Maria G. Dekker
Rankless by CCL
2026